About SGD Pharma India Private Limited
Data last updated:
SGD Pharma India Private Limited is a private limited company based in Mahbubnagar, Telangana, India, a subsidiary of Netherlands Glass Investment Bv. It operates in the pharmaceutical packaging solutions segment of the packaging sector. It was incorporated on 13 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U26100TG2009PTC065810. Its GSTIN is 36AADCC7815K1ZG (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹212 Cr and a paid-up capital of ₹207.11 Cr. It was formerly known as Sgd Pharma India Limited and Cogent Glass Limited. It is led by directors including Deepak Sood (Managing Director) and Olivier Rousseau Jean Francois.
Its last annual general meeting (AGM) was held on 20 May 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at Vemula Village Moosapet Mandal Mahbubnagar District – 509380, Telangana, India – 509380.
As per the financials filed for FY 2022, the company reported a revenue of ₹360.77 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹36.47 Cr (net margin 10.1%) and EBITDA of ₹88.32 Cr (EBITDA margin 24.5%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 23% over five years.
The company has about 572 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SGD Pharma. As per MCA filings, the company has open charges of ₹445.58 Cr and satisfied charges of ₹109.88 Cr on record. Court records list 23 cases involving the company, including 22 filed by the company and 1 filed against it; 8 cases are pending. The company has 16 deals on record (9 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹130.94 Cr; the latest was in March 2022. The company has 14 MSME Form 1 returns on record between 2018 and 2023, listing 833 overdue payments to 83 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sgd-pharma.com.
Company details
Name history
SGD Pharma India has undergone 2 name changes throughout its history. The company was previously known as Sgd Pharma India Limited, and Cogent Glass Limited. The current legal name is Sgd Pharma India Private Limited.
| Company Name | Status |
|---|---|
| SGD Pharma India Private Limited | Current |
| Sgd Pharma India Limited | Previous |
| Cogent Glass Limited | Previous |
CIN history
SGD Pharma India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U26100TG2009PTC065810, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U26100TG2009PTC065810 | Current |
| U26100TG2009PLC065810 | Previous |
| U26100AP2009PLC065810 | Previous |
Contact details
SGD Pharma India Private Limited's registered office is in Mahbubnagar, Telangana. Its website is sgd-pharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVemula Village Moosapet Mandal Mahbubnagar District – 509380, Telangana, India – 509380
- IndustryPackaging, Pharmaceutical Packaging Solutions
To see the full contact details of SGD Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
SGD Pharma India operates one associated brand: SGD Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical packaging products are manufactured for global markets. | sgd-pharma.com |
Financials of SGD Pharma India Private Limited
FY 2024 filings availableSGD Pharma India Private Limited reported revenue of ₹360.77 Cr (up 13% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 13% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹360.77 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.47 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.5% | ||||
| Net Profit Margin | 10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SGD Pharma India Private Limited, buy the company report.
Board of directors of SGD Pharma India Private Limited
SGD Pharma India has 3 current directors and 32 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Sood | Managing Director | 27 Aug 2024 | 2 Years 2 Months | Current |
| Olivier Rousseau Jean Francois Also directs: SGD Corning Technologies Private Limited | Director | 06 Oct 2022 | 4 Years 0 Months | Current |
| Philippe Henry Max Pourquery | Director | 24 Jun 2024 | 2 Years 4 Months | Current |
Auditor
SGD Pharma India Private Limited is audited by BSR & Associates LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR & Associates LLP | FY 2022 | 116231 W/W-100024 |
Shareholding
The shareholding of SGD Pharma India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SGD Pharma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Aug 2025 | 101149982 | Others | ₹12 Cr | Open | |
| 18 Mar 2024 | 100887131 | Sbicap Trustee Company Limited | ₹370.17 Cr | Open | |
| 09 Nov 2012 | 10387163 | State Bank of India | ₹63.41 Cr | Open | |
| 24 Feb 2020 | 100331363 | Others | ₹6 Lakh | Satisfied | |
| 18 Feb 2012 | 10337606 | Icici Bank Limited | ₹30 Cr | Satisfied |
To see the full charge records of SGD Pharma India Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
SGD Pharma India Private Limited has 16 deals on record (9 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹130.94 Cr; the latest was in March 2022.
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹221.25 Cr | Investors: Oaktree Capital Management |
| Oct 2021 | Secondary share transfer | Undisclosed | Buyer: Oaktree Capital Management Seller: Pravesha Industries Private Limited |
| Jan 2018 | Secondary share transfer | Undisclosed | Buyer: Oaktree Capital Management Seller: RPR Sons Advisors Private Limited & P Suneela Rani, 3 individuals |
| Apr 2013 | Acquisition | ₹43.67 Cr | Buyer: Oaktree Capital Management Seller: 4 individuals |
| Nov 2012 | Funding round | ₹62.95 Cr | Investors: 4 individuals |
To see the full deal history of SGD Pharma India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
SGD Pharma India Private Limited has 23 court cases on record: 22 filed by SGD Pharma India, 1 filed against it. 8 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 0 | 5 |
| District courts | 10 | 1 | 3 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Dhruv Life Sciences Private Limited | Pending |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against M/S. Brooks Steriscience Limited | Disposed |
| District court, Hyderabad Central, Telangana | Execution petition | Filed by the company against Pariksha Biotech Private Limited and 1 other | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against M/S. Lyka Labs Limited. | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against M/S. Pariksha Biotech Private Limited Rep. by Manager Veeram Venugopal Reddy. and 1 other | Disposed |
To see the full case history of SGD Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
SGD Pharma India Private Limited was last rated by Indiarating on 31 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 31 Aug 2021 |
To see the full credit ratings and regulatory alerts of SGD Pharma India Private Limited, buy the company report.
MSME payment delays
SGD Pharma India Private Limited has 14 MSME Form 1 returns on record between 2018 and 2023, listing 833 overdue payments to 83 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 83)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Raj Packaging Industries Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Gandhi Automations Private Limited | |||
| Megha Industries |
To see the full MSME payment records of SGD Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
SGD Pharma India Private Limited has a workforce of 572 employees on its EPFO records as of May 10, 2024, across 1 active EPFO establishment.
GST
SGD Pharma India has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCC7815K1ZG | Telangana | Active | 01 Jul 2017 |
| 24AADCC7815K1ZL | Gujarat | Active | 16 Sep 2020 |
To see the full GST registrations and return filing status of SGD Pharma India Private Limited, buy the company report.
Recent activity
SGD Pharma India Private Limited has 33 board changes on record since 2012: 4 appointments and 29 cessations. The latest: Deepak Sood was appointed as Managing Director on 27 Aug 2024.
38 earlier events are in the company report.
Frequently asked questions
SGD Pharma India is an active private limited company based in Mahbubnagar, Telangana, India. The company works in pharmaceutical packaging solutions, within the packaging industry. It was incorporated on 13 November 2009 (17+ years old) and is registered under CIN U26100TG2009PTC065810.
SGD Pharma India has 3 current directors:
- Deepak Sood - Managing Director
- Olivier Rousseau Jean Francois - Director
- Philippe Henry Max Pourquery - Director
The latest financial statements of SGD Pharma India on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 20 May 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of SGD Pharma India is 36AADCC7815K1ZG, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 24AADCC7815K1ZL (Gujarat).
The CIN (Corporate Identification Number) of SGD Pharma India is U26100TG2009PTC065810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SGD Pharma India has 23 court cases on record: 22 filed by the company and 1 filed against it. 8 are pending. Most are in the high courts.
SGD Pharma India was incorporated on 13 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
SGD Pharma India has 16 deals on record (9 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹130.94 Cr; the latest was in March 2022.
Deepak Sood was appointed as Managing Director on 27 Aug 2024. Deepak Sood ceased to be Additional Director on 27 Aug 2024. Mukul Kumar ceased to be Additional Director on 19 Jul 2024. SGD Pharma India has 33 board changes on record in total.
SGD Pharma India has 14 MSME Form 1 returns on record between 2018 and 2023, listing 833 overdue payments to 83 micro and small suppliers. The latest return was filed on 29 Aug 2023.
SGD Pharma India can be reached through the website sgd-pharma.com. Its registered office is in Mahbubnagar, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
